{"id":42975,"date":"2024-12-13T09:29:59","date_gmt":"2024-12-13T08:29:59","guid":{"rendered":"https:\/\/swedenbio.se\/vicore-pharma-takes-home-2024-swedenbio-award\/"},"modified":"2024-12-13T09:29:59","modified_gmt":"2024-12-13T08:29:59","slug":"vicore-pharma-takes-home-2024-swedenbio-award","status":"publish","type":"post","link":"https:\/\/swedenbio.se\/en\/vicore-pharma-takes-home-2024-swedenbio-award\/","title":{"rendered":"Vicore Pharma takes home 2024 SwedenBIO Award"},"content":{"rendered":"\n
Vicore Pharma was founded in the early 2000s based on the design and synthesis of buloxibutid (C21) by Professor Anders Hallberg\u2019s group at Uppsala University. The company is unlocking the potential of a new class of drugs \u2013 Angiotensin II Type 2 Receptor Agonists (ATRAGs) \u2013 stopping disease progression and restoring function. As a result of the pioneering work with buloxibutid, the first-in-class AT2 receptor agonist (ATRAG), the company now develops a portfolio of products for the treatment of rare lung diseases and following that, a clinical platform with novel compounds for a broad range of indications.<\/p>\n\n\n\n
The award was presented to Vicore by Anders Persson, chairman of SwedenBIOs board, with the following motivation: \u201cVicore is an innovative clinical-stage pharmaceutical company at the forefront of addressing unmet medical needs in rare diseases. This company is redefining therapeutic possibilities with its pioneering lead program targeting idiopathic pulmonary fibrosis (IPF), a devastating lung disease with limited treatment options. During 2024 significant milestones has been achieved as a positive Phase 2a data showcasing an attractive benefit-risk profile for its lead candidate, successfully securing one of Sweden\u2019s largest biotech raises in 2024, signing a strategic licensing agreement with a partner in Japan and launching a global Phase 2b trial in IPF.\u201d<\/p>\n\n\n\n
\n
I think what underlies our achievements is an incredible ecosystem in Sweden<\/p>\n<\/blockquote>\n\n\n\n
\u201cIt\u2019s been an incredible year for Vicore, and the credit goes to our amazing team. I think what underlies our achievements is an incredible ecosystem in Sweden. We\u2019re very excited now with the capital that we have obtained to advance our lead program into late stage clicinal development for idiophatic pulmonary fibrosis. We\u2019re very excited as a Swedish company to potentially be able to change the lives of patients suffering from this disease as a first place where we play a role and to then go further beyond that, Ahmad Mousa, the CEO of Vicore Pharma said. <\/p>\n\n\n\nVicore’s CEO Ahmed Mousa receiving the SwedenBIO Award from Anders Persson, chairman of the SwedenBIO board. <\/figcaption><\/figure>\n\n\n\n
This year\u2019s three award finalists were Vicore Pharma, Xbrane Biopharma and Pelago Bioscience. The SwedenBIO Award is given annually in collaboration with HealthCap to a member company that has shown outstanding achievements and contributions to society and that exemplifies the potential of a strong Swedish life-science industry.<\/p>\n\n\n\n
\u201cWe have supported this award for a number of years, and we will continue to do so, because it is an important factor in making sure we have a strong local network and ecosystem. Life science is a tough industry where success doesn\u2019t come easy, which is why it\u2019s important to celebrate when things turn out the right way. It\u2019s a no brainer for us to sponsor the SwedenBIO award, said Carl Kilander, Partner at HealthCap, who handed out the award onstage at the summit. <\/p>\n\n\n\n
The jury consisted of SwedenBIO\u2019s board: <\/strong>Anders Persson, AstraZeneca Kerstin Falck, Pfizer Ren\u00e9e Aguiar-Lucander, Calliditas Christine Wesstr\u00f6m, Sobi Sara Corin, Cytiva M\u00e5rten Winge, Strike Pharma Carl Kilander, HealthCap Sana Alajmovic, Sigrid Therapeutics<\/p>\n","protected":false},"excerpt":{"rendered":"
Vicore Pharma was founded in the early 2000s based on the design and synthesis of buloxibutid (C21) by Professor Anders Hallberg\u2019s group at Uppsala University. The company is unlocking the potential of a new class of drugs \u2013 Angiotensin II Type 2 Receptor Agonists (ATRAGs) \u2013 stopping disease progression and restoring function. As a result […]<\/p>\n","protected":false},"author":44,"featured_media":40602,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"_uf_show_specific_survey":0,"_uf_disable_surveys":false,"footnotes":""},"categories":[77,102],"tags":[],"class_list":["post-42975","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-industry-news","category-swedenbio-news"],"acf":[],"aioseo_notices":[],"yoast_head":"\n
Vicore Pharma takes home 2024 SwedenBIO Award - SwedenBIO<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/swedenbio.se\/en\/vicore-pharma-takes-home-2024-swedenbio-award\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Vicore Pharma takes home 2024 SwedenBIO Award - SwedenBIO\" \/>\n<meta property=\"og:description\" content=\"Vicore Pharma was founded in the early 2000s based on the design and synthesis of buloxibutid (C21) by Professor Anders Hallberg\u2019s group at Uppsala University. The company is unlocking the potential of a new class of drugs \u2013 Angiotensin II Type 2 Receptor Agonists (ATRAGs) \u2013 stopping disease progression and restoring function. As a result […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/swedenbio.se\/en\/vicore-pharma-takes-home-2024-swedenbio-award\/\" \/>\n<meta property=\"og:site_name\" content=\"SwedenBIO\" \/>\n<meta property=\"article:published_time\" content=\"2024-12-13T08:29:59+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/swedenbio.se\/wp-content\/uploads\/2024\/12\/4p1a2142-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1707\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Afram Yakoub\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Afram Yakoub\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/swedenbio.se\\\/en\\\/vicore-pharma-takes-home-2024-swedenbio-award\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/swedenbio.se\\\/en\\\/vicore-pharma-takes-home-2024-swedenbio-award\\\/\"},\"author\":{\"name\":\"Afram Yakoub\",\"@id\":\"https:\\\/\\\/swedenbio.se\\\/en\\\/#\\\/schema\\\/person\\\/f0056e52d067b9db4c55ec102b440d85\"},\"headline\":\"Vicore Pharma takes home 2024 SwedenBIO Award\",\"datePublished\":\"2024-12-13T08:29:59+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/swedenbio.se\\\/en\\\/vicore-pharma-takes-home-2024-swedenbio-award\\\/\"},\"wordCount\":506,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/swedenbio.se\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/swedenbio.se\\\/en\\\/vicore-pharma-takes-home-2024-swedenbio-award\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/swedenbio.se\\\/wp-content\\\/uploads\\\/2024\\\/12\\\/4p1a2162-scaled.jpg\",\"articleSection\":[\"Industry news\",\"SwedenBIO news\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/swedenbio.se\\\/en\\\/vicore-pharma-takes-home-2024-swedenbio-award\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/swedenbio.se\\\/en\\\/vicore-pharma-takes-home-2024-swedenbio-award\\\/\",\"url\":\"https:\\\/\\\/swedenbio.se\\\/en\\\/vicore-pharma-takes-home-2024-swedenbio-award\\\/\",\"name\":\"Vicore Pharma takes home 2024 SwedenBIO Award - SwedenBIO\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/swedenbio.se\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/swedenbio.se\\\/en\\\/vicore-pharma-takes-home-2024-swedenbio-award\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/swedenbio.se\\\/en\\\/vicore-pharma-takes-home-2024-swedenbio-award\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/swedenbio.se\\\/wp-content\\\/uploads\\\/2024\\\/12\\\/4p1a2162-scaled.jpg\",\"datePublished\":\"2024-12-13T08:29:59+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/swedenbio.se\\\/en\\\/vicore-pharma-takes-home-2024-swedenbio-award\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/swedenbio.se\\\/en\\\/vicore-pharma-takes-home-2024-swedenbio-award\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/swedenbio.se\\\/en\\\/vicore-pharma-takes-home-2024-swedenbio-award\\\/#primaryimage\",\"url\":\"https:\\\/\\\/swedenbio.se\\\/wp-content\\\/uploads\\\/2024\\\/12\\\/4p1a2162-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/swedenbio.se\\\/wp-content\\\/uploads\\\/2024\\\/12\\\/4p1a2162-scaled.jpg\",\"width\":2560,\"height\":1707,\"caption\":\"Vicore Pharma SwedenBIO Award 2024\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/swedenbio.se\\\/en\\\/vicore-pharma-takes-home-2024-swedenbio-award\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Hem\",\"item\":\"https:\\\/\\\/swedenbio.se\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Vicore Pharma takes home 2024 SwedenBIO Award\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/swedenbio.se\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/swedenbio.se\\\/en\\\/\",\"name\":\"SwedenBIO\",\"description\":\"Branschorganisationen f\u00f6r svenska life science f\u00f6retag\",\"publisher\":{\"@id\":\"https:\\\/\\\/swedenbio.se\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/swedenbio.se\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/swedenbio.se\\\/en\\\/#organization\",\"name\":\"SwedenBIO\",\"url\":\"https:\\\/\\\/swedenbio.se\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/swedenbio.se\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/swedenbio.se\\\/wp-content\\\/uploads\\\/2020\\\/09\\\/logo.png\",\"contentUrl\":\"https:\\\/\\\/swedenbio.se\\\/wp-content\\\/uploads\\\/2020\\\/09\\\/logo.png\",\"width\":240,\"height\":59,\"caption\":\"SwedenBIO\"},\"image\":{\"@id\":\"https:\\\/\\\/swedenbio.se\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/swedenbio.se\\\/en\\\/#\\\/schema\\\/person\\\/f0056e52d067b9db4c55ec102b440d85\",\"name\":\"Afram Yakoub\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/030b5b2b9cdaa6cb7449b81a7abf5a7c3d21d205830126e81faebda674de42ae?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/030b5b2b9cdaa6cb7449b81a7abf5a7c3d21d205830126e81faebda674de42ae?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/030b5b2b9cdaa6cb7449b81a7abf5a7c3d21d205830126e81faebda674de42ae?s=96&d=mm&r=g\",\"caption\":\"Afram Yakoub\"},\"sameAs\":[\"http:\\\/\\\/www.swedenbio.se\"],\"url\":\"https:\\\/\\\/swedenbio.se\\\/en\\\/author\\\/afram-yakoub\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Vicore Pharma takes home 2024 SwedenBIO Award - SwedenBIO","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/swedenbio.se\/en\/vicore-pharma-takes-home-2024-swedenbio-award\/","og_locale":"en_US","og_type":"article","og_title":"Vicore Pharma takes home 2024 SwedenBIO Award - SwedenBIO","og_description":"Vicore Pharma was founded in the early 2000s based on the design and synthesis of buloxibutid (C21) by Professor Anders Hallberg\u2019s group at Uppsala University. The company is unlocking the potential of a new class of drugs \u2013 Angiotensin II Type 2 Receptor Agonists (ATRAGs) \u2013 stopping disease progression and restoring function. As a result […]","og_url":"https:\/\/swedenbio.se\/en\/vicore-pharma-takes-home-2024-swedenbio-award\/","og_site_name":"SwedenBIO","article_published_time":"2024-12-13T08:29:59+00:00","og_image":[{"width":2560,"height":1707,"url":"https:\/\/swedenbio.se\/wp-content\/uploads\/2024\/12\/4p1a2142-scaled.jpg","type":"image\/jpeg"}],"author":"Afram Yakoub","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Afram Yakoub","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/swedenbio.se\/en\/vicore-pharma-takes-home-2024-swedenbio-award\/#article","isPartOf":{"@id":"https:\/\/swedenbio.se\/en\/vicore-pharma-takes-home-2024-swedenbio-award\/"},"author":{"name":"Afram Yakoub","@id":"https:\/\/swedenbio.se\/en\/#\/schema\/person\/f0056e52d067b9db4c55ec102b440d85"},"headline":"Vicore Pharma takes home 2024 SwedenBIO Award","datePublished":"2024-12-13T08:29:59+00:00","mainEntityOfPage":{"@id":"https:\/\/swedenbio.se\/en\/vicore-pharma-takes-home-2024-swedenbio-award\/"},"wordCount":506,"commentCount":0,"publisher":{"@id":"https:\/\/swedenbio.se\/en\/#organization"},"image":{"@id":"https:\/\/swedenbio.se\/en\/vicore-pharma-takes-home-2024-swedenbio-award\/#primaryimage"},"thumbnailUrl":"https:\/\/swedenbio.se\/wp-content\/uploads\/2024\/12\/4p1a2162-scaled.jpg","articleSection":["Industry news","SwedenBIO news"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/swedenbio.se\/en\/vicore-pharma-takes-home-2024-swedenbio-award\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/swedenbio.se\/en\/vicore-pharma-takes-home-2024-swedenbio-award\/","url":"https:\/\/swedenbio.se\/en\/vicore-pharma-takes-home-2024-swedenbio-award\/","name":"Vicore Pharma takes home 2024 SwedenBIO Award - SwedenBIO","isPartOf":{"@id":"https:\/\/swedenbio.se\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/swedenbio.se\/en\/vicore-pharma-takes-home-2024-swedenbio-award\/#primaryimage"},"image":{"@id":"https:\/\/swedenbio.se\/en\/vicore-pharma-takes-home-2024-swedenbio-award\/#primaryimage"},"thumbnailUrl":"https:\/\/swedenbio.se\/wp-content\/uploads\/2024\/12\/4p1a2162-scaled.jpg","datePublished":"2024-12-13T08:29:59+00:00","breadcrumb":{"@id":"https:\/\/swedenbio.se\/en\/vicore-pharma-takes-home-2024-swedenbio-award\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/swedenbio.se\/en\/vicore-pharma-takes-home-2024-swedenbio-award\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/swedenbio.se\/en\/vicore-pharma-takes-home-2024-swedenbio-award\/#primaryimage","url":"https:\/\/swedenbio.se\/wp-content\/uploads\/2024\/12\/4p1a2162-scaled.jpg","contentUrl":"https:\/\/swedenbio.se\/wp-content\/uploads\/2024\/12\/4p1a2162-scaled.jpg","width":2560,"height":1707,"caption":"Vicore Pharma SwedenBIO Award 2024"},{"@type":"BreadcrumbList","@id":"https:\/\/swedenbio.se\/en\/vicore-pharma-takes-home-2024-swedenbio-award\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Hem","item":"https:\/\/swedenbio.se\/en\/"},{"@type":"ListItem","position":2,"name":"Vicore Pharma takes home 2024 SwedenBIO Award"}]},{"@type":"WebSite","@id":"https:\/\/swedenbio.se\/en\/#website","url":"https:\/\/swedenbio.se\/en\/","name":"SwedenBIO","description":"Branschorganisationen f\u00f6r svenska life science f\u00f6retag","publisher":{"@id":"https:\/\/swedenbio.se\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/swedenbio.se\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/swedenbio.se\/en\/#organization","name":"SwedenBIO","url":"https:\/\/swedenbio.se\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/swedenbio.se\/en\/#\/schema\/logo\/image\/","url":"https:\/\/swedenbio.se\/wp-content\/uploads\/2020\/09\/logo.png","contentUrl":"https:\/\/swedenbio.se\/wp-content\/uploads\/2020\/09\/logo.png","width":240,"height":59,"caption":"SwedenBIO"},"image":{"@id":"https:\/\/swedenbio.se\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/swedenbio.se\/en\/#\/schema\/person\/f0056e52d067b9db4c55ec102b440d85","name":"Afram Yakoub","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/030b5b2b9cdaa6cb7449b81a7abf5a7c3d21d205830126e81faebda674de42ae?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/030b5b2b9cdaa6cb7449b81a7abf5a7c3d21d205830126e81faebda674de42ae?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/030b5b2b9cdaa6cb7449b81a7abf5a7c3d21d205830126e81faebda674de42ae?s=96&d=mm&r=g","caption":"Afram Yakoub"},"sameAs":["http:\/\/www.swedenbio.se"],"url":"https:\/\/swedenbio.se\/en\/author\/afram-yakoub\/"}]}},"_links":{"self":[{"href":"https:\/\/swedenbio.se\/en\/wp-json\/wp\/v2\/posts\/42975","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/swedenbio.se\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/swedenbio.se\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/swedenbio.se\/en\/wp-json\/wp\/v2\/users\/44"}],"replies":[{"embeddable":true,"href":"https:\/\/swedenbio.se\/en\/wp-json\/wp\/v2\/comments?post=42975"}],"version-history":[{"count":0,"href":"https:\/\/swedenbio.se\/en\/wp-json\/wp\/v2\/posts\/42975\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/swedenbio.se\/en\/wp-json\/wp\/v2\/media\/40602"}],"wp:attachment":[{"href":"https:\/\/swedenbio.se\/en\/wp-json\/wp\/v2\/media?parent=42975"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/swedenbio.se\/en\/wp-json\/wp\/v2\/categories?post=42975"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/swedenbio.se\/en\/wp-json\/wp\/v2\/tags?post=42975"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
![\"\"](\"https:\/\/swedenbio.se\/wp-content\/uploads\/2024\/12\/4p1a2142-1024x683.jpg\")